Michael Scolaro

Michael Scolaro

Sep 10, 2017

Group 6 Copy 184
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    The Dogs of Chernobyl Research Initiative

    The Chernobyl disaster site has hundreds of feral dogs that are in need of care. A team of students from...

    Are coyotes contributing to the spread Rocky Mountain spotted fever in Arizona?

    Rocky Mountain spotted fever (RMSF) is a tick-borne bacterial infection that can cause permanent disability...

    The Effects of Sudarshan Kriya Yoga (SKY) in patients with Post Traumatic Stress Disorder (PTSD)

    Sudarshan Kriya Yoga (SKY) is a standardized series of breathing techniques that has beneficial effects...

    Backer Badge Funded